Changeflow GovPing Healthcare Dexcom, Inc. - Glucose Prediction Method Patent...
Routine Notice Added Final

Dexcom, Inc. - Glucose Prediction Method Patent Application EP4664486A3

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Health Informatics (G16H)
Published March 18th, 2026
Detected March 23rd, 2026
Email

Summary

The European Patent Office has published patent application EP4664486A3 by Dexcom, Inc. for a method of predicting future blood glucose concentrations using individualized linear black box models. The application details a technique involving estimating impulse response functions within a Reproducing Kernel Hilbert Space and applying linear prediction.

What changed

European patent application EP4664486A3, filed by Dexcom, Inc., describes a novel method for predicting future blood glucose concentrations. The method involves creating an individualized linear black box model of glucose-insulin dynamics by estimating impulse response functions within a Reproducing Kernel Hilbert Space (RKHS). This model is then used with a linear predicting technique to forecast future glucose levels.

This publication represents a new patent application and does not impose immediate compliance obligations. However, companies in the health informatics and medical device sectors, particularly those involved in glucose monitoring and diabetes management, should be aware of this technological development. The application is designated for several European states, indicating potential future market relevance.

Source document (simplified)

← EPO Patent Bulletin

NONPARAMETRIC GLUCOSE PREDICTORS

Search Report EP4664486A3 Kind: A3 Mar 18, 2026

Applicants

Dexcom, Inc.

Inventors

DEL FAVERO, Simone, FACCHINETTI, Andrea, FACCIOLI, Simone, PILLONETTO, Gianluigi, SPARACINO, Giovanni

Abstract

A method of predicting future blood glucose concentrations of an individual patient includes: identifying an individualized linear black box model of glucose-insulin by estimating a plurality of impulse response functions each accounting for an input-output relation of a plurality of individualized patient data sets, the impulse response functions being functions in a Reproducing Kernel Hilbert Space (RKHS); and applying a linear predicting technique to the selected model using the identified impulse response functions to obtain a predicted blood glucose concentration of the individual patient at a future time.

IPC Classifications

G16H 50/20 20180101AFI20260206BHEP G16H 50/50 20180101ALI20260206BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

NONPARAMETRIC GLUCOSE PREDICTORS Applicants Inventors Abstract IPC Classifications Designated States

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4664486A3

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Industry sector
3345 Medical Device Manufacturing 3254 Pharmaceutical Manufacturing
Activity scope
Glucose Prediction Medical Data Analysis
Geographic scope
European Union EU

Taxonomy

Primary area
Healthcare
Operational domain
R&D
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Medical Devices Data Analytics

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Health Informatics (G16H) publishes new changes.

Free. Unsubscribe anytime.